In conjunction with the traditional vaccination approach, Johnson & Johnson partnered with local officials to introduce a second vaccine to address the surge in Ebola outbreaks. A ring vaccination strategy will be implemented to counter the potential shortage of the traditional vaccine used.
Johnson & Johnson will provide additional supplemental new vaccines to cover 1.5 million people in the Congo area to combat the Ebola outbreaks by working in conjunction with existing vaccine strategies.